DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $493,677 | +7.6% | 2,038 | +10.9% | 0.05% | 0.0% |
Q1 2024 | $458,885 | +33.7% | 1,837 | +23.2% | 0.05% | +27.0% |
Q4 2023 | $343,302 | +8.1% | 1,491 | +1.5% | 0.04% | +5.7% |
Q3 2023 | $317,481 | +16.7% | 1,469 | +26.5% | 0.04% | +16.7% |
Q2 2023 | $272,154 | -28.8% | 1,161 | -25.0% | 0.03% | -31.8% |
Q1 2023 | $382,486 | +8.4% | 1,549 | +20.2% | 0.04% | -6.4% |
Q4 2022 | $352,823 | +68.0% | 1,289 | +60.7% | 0.05% | +38.2% |
Q3 2022 | $210,000 | -3.2% | 802 | -2.7% | 0.03% | +6.2% |
Q2 2022 | $217,000 | -14.2% | 824 | -2.4% | 0.03% | -3.0% |
Q1 2022 | $253,000 | -7.7% | 844 | +1.2% | 0.03% | -2.9% |
Q4 2021 | $274,000 | -50.0% | 834 | -53.5% | 0.03% | -51.4% |
Q3 2021 | $548,000 | +67.6% | 1,792 | +47.0% | 0.07% | +62.8% |
Q2 2021 | $327,000 | -42.9% | 1,219 | -62.4% | 0.04% | -51.1% |
Q2 2020 | $573,000 | +12.4% | 3,243 | -12.0% | 0.09% | -2.2% |
Q1 2020 | $510,000 | – | 3,687 | – | 0.09% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |